Research Article
What Is the Role of Apelin regarding Cardiovascular Risk and Progression of Renal Disease in Type 2 Diabetic Patients with Diabetic Nephropathy?
Table 1
Patients’ baseline characteristics.
| | Characteristics | Values |
| | Number of patients enrolled, | 150 | | Age (years) | 62.67 ± 10.95 | | Gender, M/F (%) | 92/58 (61.3/38.7) | | BMI (Kg/m2) | 26.3 ± 2.7 | | Blood pressure (mmHg) | 130.9/77.4 ± 18.1/10.9 | | Hb (g/dL) | 12.6 ± 1.9 | | HgA1c (%) | 7.5 ± 1.5 | | Total cholesterol (mg/dL) | 192.7 ± 40.1 | | Triglycerides (mg/dL) | 154.8 ± 88.9 | | PTH (pg/mL) | 138.9 ± 50.8 | | Phosphorus (mg/dL) | 4.3 ± 1.2 | | Calcium (mg/dL) | 9.4 ± 0.9 | | Creatinine (mg/dL) | 1.9 ± 1.0 | | Albumin/creatinine ratio (g/mg) | 244.9 ± 116.0 | | eGFR (mL/min) | 42.7 ± 23.6 | | Albumin (g/dL) | 4.1 ± 0.6 | | HDL (mg/dL) | 50.4 ± 20.8 | | LDL (mg/dL) | 113.0 ± 30.7 | | Apelin (pg/mL) | 216.2 ± 45.3 | | IL-6 (pg/mL) | 6.2 ± 3.8 | | Resistin (pg/mL) | 6.1 ± 3.5 | | Visfatin (pg/mL) | 62.0 ± 59.7 | | Adiponectin (ng/mL) | 28.6 ± 8.6 | | OxLDL (U/L) | 45.7 ± 22.8 | | LVMI (g/m2) | 105.2 ± 25.7 | | PP (mmHg) | 53.1 ± 19.3 |
|
|
